Pre-existing immunity played a significant role in protection during the latest influenza A virus H1N1 pandemic, especially in older age groups. Structural similarities were found between A(H1N1)2009 and older H1N1 virus strains to which humans had already been exposed. Broadly cross-reactive antibodies capable of neutralizing the A(H1N1)2009 virus have been implicated in this immune protection in adults. We investigated the serological profile of a group of young children aged 9 years (n=55), from whom paired blood samples were available, just prior to the pandemic wave (March 2009) and shortly thereafter (March 2010). On the basis of A(H1N1)2009 seroconversion, 27 of the 55 children (49 %) were confirmed to be infected between these two time points. Within the non-infected group of 28 children (51 %), high levels of seasonal antibodies to H1 and H3 HA1 antigens were detected prior to pandemic exposure, reflecting past infection with H1N1 and H3N2, both of which had circulated in The Netherlands prior to the pandemic. In some children, this reactivity coincided with specific antibody reactivity against A(H1N1)2009. While these antibodies were not able to neutralize the A(H1N1)2009 virus, they were able to mediate antibody-dependent cellular cytotoxicity (ADCC) in vitro upon interaction with the A(H1N1)2009 virus. This finding suggests that cross-reactive antibodies could contribute to immune protection in children via ADCC.
INTRODUCTION
Influenza A virus infection remains a major public health burden as a result of the continuous, rapidly mutating nature of the virus, which enables it to evade immune systems. Genetic re-assortment can lead to viruses with surface proteins that are antigenically distinct from those of seasonal strains. Haemagglutinin (HA) is the immunodominant surface protein, consisting of a globular head containing the receptor-binding site (HA1) and the stalk (HA2) domain. HA1 is the most variable part and is involved in the induction of virus-neutralizing antibodies, which is considered a major correlate of protection. The introduction of a novel HA-containing virus can result in pandemics as large groups of people are considered immunologically naïve because of the absence of such antibodies (Skehel & Wiley, 2000) . While HA proteins of seasonal influenza viruses are of the subtype H1-3, a wider diversity of influenza viruses is observed in animal reservoirs.
The most recent pandemic was the swine-origin influenza A H1N1 in 2009 (A(H1N1)2009) (Watanabe et al., 2014) . Despite the large antigenic distance between the HA of A(H1N1)2009 and the HA of seasonal influenza virus strains (Garten et al., 2009) , the impact of the pandemic was lower than expected because of pre-existing immunity in many adults. Since 2009, it has been shown that people of increasing age were better protected. Persons born before the 1940s were most protected against the A (H1N1)2009, which has been related to the similarity between the HA1 of the 1918 and 2009 pandemic strains Xu et al., 2010) ; however, some protection was also observed in younger adults. Cross-neutralizing antibodies have been implicated in this immune protection, possibly resulting from the boosting of antibodies that had developed against previous seasonal strains ( Corti et al., 2010 Corti et al., , 2011 Ekiert et al., 2009; Li et al., 2012; Throsby et al., 2008; Wrammert et al., 2011) . However, cross-reactive antibodies were hardly detected among children aged 6 months to 9 years (Hancock et al., 2009) .
Recently, non-neutralizing functions of antibodies have been implicated in immune protection as well. Interaction between antibodies on the surface of influenza virus-infected cells and the Fcg-receptor(R) on natural killer (NK) cells results in the killing of those cells, a process called antibodydependent cellular cytotoxicity (ADCC) (reviewed in (Jegaskanda et al., 2014a) . It has been suggested that the recruitment of these antibody-mediated Fc-FcgR-expressing effector cells by antibodies is a major in vivo mechanism of antibody-mediated protection from infection (DiLillo et al., 2014; Schmitz et al., 2012) . DiLillo et al. showed that broadly cross-reactive antibodies (bNAbs) directed against the HA stalk domain were able to induce ADCC, whereas the bNAbs against the head domain were not, showing a poor interaction of the more specific HA-head Ab with the FcgRs. However, induction of ADCC was also recently demonstrated by non-neutralizing Abs directed against the HA1 head domain, although the role of the Fc receptor was not further determined (Jegaskanda et al., 2013a) . The presence of ADCCmediating antibodies against A(H1N1)2009 was described in adults prior to the pandemic outbreak (aged <45 years), and against H5N1 and H7N9 in adults and children aged !8 years, who were unlikely to have been exposed to those avian subtypes (Terajima et al., 2015) .
To obtain more insights into the role and development of cross-reactive antibodies and their potential role in the observed immune protection against A(H1N1)2009, we used a protein microarray (PA) to dissect antibody reactivity profiles for seasonal and pandemic influenza A strains (Baas et al., 2013; de Bruin et al., 2014; Freidl et al., 2015; Koopmans et al., 2012) . We analysed paired serum samples from children aged 9-10 years, collected shortly before and just after the 2009 pandemic. Subsequently, we studied the neutralizing and non-neutralizing functions of the different reactive antibodies with virus neutralization assays and ADCC.
RESULTS

Identification of A(H1N1)2009 infected and noninfected children
We investigated A(H1N1)2009 seroconversion in 55 children aged 9 years from whom paired longitudinal serum samples were available just prior to the first pandemic wave in 2009 (March 2009) and shortly thereafter (March 2010) . The serum samples were tested by PA for reactivity against recombinant HA1 antigen from A(H1N1)2009 virus. PA serum titres were established for each serum pair. A(H1N1) 2009 seroconversion -defined by a minimal two-fold titre increase and a post-pandemic titre >40 -indicated that 27 of 55 children (49.1 %) had been infected with the A (H1N1)2009 virus between these two time points (Fig. 1) . The remainder of the children (n=28, 50.9 %) did not seroconvert, but four children in this selection showed pre-and post-pandemic A(H1N1)2009 reactivity on the protein array (Fig. 1, indicated (Fig. 2a, b) . The four children within the non-infected group that already showed pre-pandemic A(H1N1)2009 reactivity ( Fig. 1 ; #4, #41, #42 and #55) also showed reactivity against A(H1N1)1918, with titre values >40 ( Fig. 2a ; #4, #41, #42, #52, indicated in red). This reactivity probably reflects exposure to the seasonal influenza virus prior to the pandemic wave, since the titres of three children decreased to values <40 a year later (Figs 1 and 2a) . Notably, pre-pandemic sH1N1-2007 Notably, pre-pandemic sH1N1- and sH3N2 2003 Notably, pre-pandemic sH1N1- /2007 GMT titres were generally higher in the non-infected group (Fig. 2b, c) . Furthermore, a significant decrease was observed in sH3N2 2003/2007 GMT in the non-infected group (Fig. 2c ) and likely reflects waning serum IgG levels. These data indicate that children within the non-infected group were likely exposed to H3N2 shortly before the introduction of A(H1N1)2009.
Neutralization of A(H1N1)2009
To investigate whether the cross-reactive A(H1N1)2009 antibodies might play a role in immune protection against A(H1N1)2009, paired pre-and post-pandemic serum samples of children were tested to correlate strain-specific antibody binding by PA to virus neutralization (VN). Virus neutralization titres of all post-pandemic samples within the seroconverted group (n=27) were >64, which corroborates our PA-based criteria that these children had indeed been infected. The VN titres of the post-pandemic samples positively correlated (r=0.4502, P<0.0001) with the measured PA titre against the virus. (Fig. 3a) . None of the prepandemic serum samples showed neutralizing activity, including those that showed A(H1N1)2009-reactive antibodies (Fig. 3b) .
ADCC induction pre-and post-A(H1N1)2009 infection
To study whether antibodies from children could mediate specific ADCC in response to A(H1N1)2009, we measured ADCC using HA1, HA trimer and live virus as antigen protocol in which the activity of natural killer (NK) cells is measured using flow cytometry (Jegaskanda et al., 2013a) (Fig. 4) . In addition to the release of NK-mediated IFN-g in the original protocol to measure NK cell activity, we also measured the release of perforin from NK cells, which is elementary for the killing of infected target cells (Voskoboinik et al., 2015) . Overall, we showed that the sera containing a PA titre against HA1 A(H1N1) induced an increase in % IFNg/CD107A-positive NK cells ( Fig. 5a ) and a simultaneous decrease in the percentage of perforin/ CD107a-positive NK cells, which visualizes the loss of perforin as it is released prior to staining (Fig. 5b ). NK cell activity was seen in post-pandemic serum samples from the infected group (#67, #9, #53 and #54, Fig. 5 ) and in pre-pandemic serum samples that showed A(H1N1) 2009 cross-reactivity in the PA assay, which includes the two serum samples with high sH1N1 and sH3N2 titres (#3 and #51, Figs 2 and 5). The response pattern for the HA1 protein or the HA trimer coated on the plates was similar, indicating that HA1-specific binding on the PA represents, or at least overlaps with, the total HA antibody repertoire. Notably, the highest induction of ADCC in response to HA1 or the HA trimer was detected in the pre-pandemic samples (#3 and #51, Fig. 5 Several studies have shown pre-existing immunity against A(H1N1)2009 in adults (Corti et al., 2010 (Corti et al., , 2011 Ekiert et al., 2009; Throsby et al., 2008) , whereas little or no preexisting cross-reactive antibodies were detected in a group of 124 children aged 6 months to 9 years (Hancock et al., 2009) . In our cohort, 49.1 % of the children showed A (H1N1)2009 seroconversion, which allowed us to follow the development of humoral anti-influenza responses that were explicitly induced by infection with A(H1N1)2009 despite the lack of clinical and virological data to support this. In addition, these children were most likely exposed to only a limited number of influenza viruses.
In the A(H1N1)2009-infected group, we observed homosubtypic anti-H1 cross-reactivity, particularly against A (H1N1)1918. This observation can be explained by the HA1-1918/2009 sequence homology Xu et al., 2010) , which is apparently also present in the H1-2007 antigen. Compared with what has been shown in adults, the post-pandemic responses were less broad, whereas in adults, A(H1N1)2009 exposure resulted in broad, heterosubtypic anti-HA antibodies that cross-reacted with multiple group 1 and group 2 strains (Ahmed et al., 2015; Corti et al., 2011; Wrammert et al., 2011) . The relative absence of broadly reactive antibodies in children could indicate that a repeated encounter with influenza virus in life is required to drive the induction and boosting of memory B cells with a more heterologous antibody specificity. Furthermore, many broad cross-reactive antibodies target the HA2 domain, which is not presented in our array (Greenbaum et al., 2009; Li et al., 2012) .
In a previous study, we observed a trend between high seasonal H1N1 titres and absence of A(H1N1)2009 infection (Baas et al., 2013) . In the present study, we extended the survey to include a much larger group of children and confirmed this association. Strikingly, we also found an association between non-infection and high H3N2 titres. Since the concentrations of these antibodies had also decreased in the post-pandemic serum samples, these high seasonal H1 and H3 titres reflected recent influenza exposures. Cross-reactive antibody concentrations against 1918/ 2009 H1N1 strains also decreased in post-pandemic samples, suggesting that these responses were related to the seasonal infection. Indeed, it is known that seasonal H1N1 infections can contribute to the priming of crossreactive immunity or may prevent a severe clinical outcome of acute A(H1N1)2009 infection (Haran et al., 2014; Lemaitre et al., 2011) . Since H1 and H3 strains belong to a phylogenetically different group, recent exposures might induce (short-term) overall immune protection, which especially concerns a possible contribution of H3N2 to the immune protection against A(H1N1)2009. Here, crossreactive T-cells could contribute much more to this immune protection (Greenbaum et al., 2009 responses could be present in the absence of serum IgG, as has been shown earlier for some children (Baas et al., 2013) . A further study of the responses on memory B-cell level could provide more insights into both the development of humoral immunity and the long-term effects of this cross-reactivity.
The samples containing pre-pandemic cross-reactive anti-A(H1N1)2009 antibodies did not neutralize cell infection, which is consistent with previous studies (Hancock et al., 2009; te Beest et al., 2014) . To further investigate the role of these non-neutralizing cross-reactive antibodies, we measured the A(H1N1)2009 ADCC response to both HA1 and HA trimer and live virus. Interestingly, both pre-and postpandemic anti-H1-09 antibodies induced ADCC in response to A(H1N1)2009 HA1, HA or live virus. These ADCC antibodies reconstitute a specific set of antibodies of which the properties are incompletely understood but could provide immune protection: NK cells provide a non-specific first line of immune defence, but NK-mediated ADCC also affects adaptive immunity by enabling or enhancing neutralization and T-cell responses (DiLillo et al., 2014; Schmitz et al., 2012; Tamura et al., 1993) .
Our results suggest that A(H1N1)2009 cross-reactive humoral responses could contribute to immune protection via ADCC at this young age, but it would require additional boosting of memory responses to develop cross-neutralizing antibodies. In children with pre-existing immunity, we showed that this was related to a previous exposure to seasonal strains that had circulated between 2001 and 2009 and to which most children had most likely been exposed (Bodewes et al., 2011) .
We measured the strongest A(H1N1)2009 ADCC induction in response to HA1 and HA trimer compared with that to live virus, similar to a previous report (Jegaskanda et al., 2013a) . These responses could be mediated by the same antibodies, although both HA1 and HA2 epitopes for ADCC antibodies have been reported (DiLillo et al., 2014; Jegaskanda et al., 2014b; Srivastava et al., 2013) . The role of neutralizing and non-neutralizing Abs in effector cell activation is highly dependent on the affinity of these antibodies to the Fc gamma receptor. Differences between HA binding and binding to live virus could be explained by the presence of ADCC-inducing antibodies directed against structural proteins present on the surface of infected cells, such as NP or M2 (Hashimoto et al., 1983; Jegerlehner et al., 2004; Lamb et al., 1985) . Besides the target of the antibodies, the accessibility of epitopes might play a role. Moreover, our results indicate that the detection of strain-specific ADCC antibodies in children -currently a comprehensive and labour-intensive assay -is also in accord with the detection of HA1-specific antibodies as determined by our PA.
Renewed interest in the role of non-neutralizing antibodies in protecting against influenza is related to the observation that the golden standard -the haemagglutination inhibition assay -does not always correlate with immune protection, which especially holds true for children (Black et al., 2011; Wrammert et al., 2011) . Virus neutralization and Fc-mediated effector functions, such as ADCC, could provide complementary information (Black et al., 2011; Co et al., 2014; Jegaskanda et al., 2013b) .
Our results indicate that exposure to the specific virus strain is required for neutralizing antibodies but that crossreactive ADCC antibodies can be present before exposure and at an earlier age. The presence of ADCC antibodies in children is hypothesized to reflect the number of exposures (Co et al., 2014; Jegaskanda et al., 2013b Jegaskanda et al., , 2014b . Accordingly, we observed that children with pre-pandemic H1-09 ADCC antibodies displayed high seasonal H1N1 and H3N2 titres. This knowledge of cellular immunity, like ADCC, against multiple influenza virus infections can be of great value in the development of a new generation of influenza vaccines. Vaccine-induced neutralizing antibodies to the influenza virus are strain-specific, whereas ADCCinvolved antibodies are suggested to be targeted to more conserved regions in the HA domain and possibly provide a level of protection against emerging influenza viruses.
METHODS
Samples, cells and viruses. Serum samples from 9-and 10-year-old children were collected in March 2009 and March 2010 as part of a longitudinal Bordetella Pertussis study (Trial ISRCTN64117538) (Hendrikx et al., 2011) . All participants gave informed consent and permission for use of materials to study other infectious diseases. None of the children within our cohort received influenza virus vaccine prior to or during the study period. Protein microarray. Recombinant HA1 proteins (Table 1) of influenza A viruses were printed in duplicate onto nitrocellulose slides (64 pad, ONCYTE AVID, Grace Bio-Labs, Bend, Oregon, USA) by a Piezorray spotter (Perkin Elmer, Waltham) as previously described (Koopmans et al., 2012) .
Serum samples were heat-inactivated at 56 C for 30 min and then incubated on the slides in fourfold dilutions, starting with 5 µl (1 : 40) in Blotto Blocking Buffer (Thermo Fisher Scientific Inc., Rockford, MA, USA) containing 0.1% Surfactant-Amps (Thermo Fisher Scientific Inc.).
AlexaFluor647-labelled goat-anti-human IgG (Jackson ImmunoResearch Laboratories Inc, West Grove, PA, USA) was used as conjugate. Fluorescent signals were measured with a Powerscanner (Tecan Group Ltd, M€ annedorf, Switzerland). The titre for each serum sample was defined as the interpolated serum concentration generating the 50% infection point using a four-parameter logistic nonlinear regression model as previously described (Koopmans et al., 2012) Virus neutralization. Sera were heat-inactivated for 30 min at 56 C and two-fold serially diluted (from 1 : 8) in virus growth medium [MEM (Gibco) supplemented with 40 µg ml À1 gentamycin (Sigma), 0.01 M Tricin (Sigma) and 2 µg ml À1 TPCK-treated trypsin (Sigma)]. An equal volume of virus (A/California/7/2009(H1N1)) at a concentration of 100 TCID 50 was added to each tube. In addition, a back titration of the virus stock used for incubation with the serum dilutions was prepared by ½log10 serial dilutions. Virus-serum preparations were subsequently incubated for 2 h at 37 C. The controls and the back-titration samples were transferred to 96-well plates containing a confluent monolayer of MDCK cells and incubated for another 2 h at 37 C, after which the plate was washed and fresh medium was added. Wells containing only the medium served as the control. Plates were incubated for approximately 4 days until the back-titration plate reached CPE at a titre of 100 TCID 50 .
ADCC. The ADCC protocol has been described by Jegaskanda et al. (2013a) ), was coated o/n at 4 C on ELISA plates (Immulon). Plates were washed with PBS before adding heat-inactivated sera at dilution 1 : 10, since the percentage of activated NK cells in response to this dilution correlates with the end-point ADCC titre and killing (Jegaskanda et al., 2013b) . Following 2 h incubation at 37 C, freshly isolated PBMCs (10 6 well
À1
) were incubated for 5 h on plates in RPMI supplemented with L-glutamine (2 mM), 10 % (v/v) heat-inactivated FCS, penicillin (100 U ml
) and streptomycin (100 mg ml
). Mouse-CD107a (LAMP1) antibodies, used as a marker for induced release of mediators, were added directly to the culture. The incubation was followed by extracellular and intracellular cell staining for flow cytometric analysis. As a control, cells were incubated in virus-or antigen-coated wells in the absence of serum. These background signals were subtracted from the measured percentages of CD107+ NK cells to determine relative NK cell activation.
Flow cytometry. To identify the NK cell population within PBMCs and measure the release of perforin or IFN-g from these cells, the following mouse antibodies were used: FITC-conjugated CD3 (Biolegend), PE-conjugated CD56 (Biolegend), CD107a conjugated with PerCP Cy5.5 (Biolegend), PE-Cy7-conjuated IFN-g (eBioscience), BV421-conjugated perforin (Biolegend) and live-dead fixable aqua dead cell stain (AmCyan, Invitrogen). Extracellular staining was performed in PBS/ 0.5 % BSA/2 mM EDTA. Subsequently, cells were fixed and permeabilized in Cytofix/Cytoperm buffer (BD Biosciences), and intracellular staining was performed in Perm/Wash buffer (BD Biosciences). After staining, fixation buffer (Biolegend) was added to all samples. Samples were measured on a FACS Canto II (BD Biosciences), and data were analysed using FlowJo software 7.6.5 (Tristar).
Statistical analysis. Data were analysed using Graphpad Prism 6.04. The paired and unpaired Student's t-test on log-transformed samples were used for statistics on GMT data (Olivier et al., 2008) . For correlation between titres or titres and ADCC, the Pearson correlation coefficient was calculated.
